Halozyme Therapeutics wants to take over Evotec. The US biopharmaceutical company based in San Diego is offering €2 billion for the German drug developer.
As Novartis moves toward shedding generics subsidiary Sandoz, which it touts as a global leader in off-patent generic and biosimilar drugs, Sandoz has agreed a multi-year...
German CDMO Evotec is to acquire compatriot company Central Glass Germany from Japanese owner Central Glass for a nominal price of €1. The transaction, which remains...
German biopharma Boehringer Ingelheim, compatriot CDMO Evotec and French diagnostics firm BioMérieux have formed a joint venture to develop a new approach to fight the...
German drug discovery and development company Evotec and Canadian therapeutics company Sernova are collaborating to develop a diabetes treatment based on induced...
US drugmaker Bristol Myers Squibb has chosen Leiden in the Netherlands for a new cell therapy manufacturing site in Europe as it continues to expand and develop...
German drug discovery and development group Evotec has started building a biologics manufacturing facility at its Campus Curie site in Toulouse, France.
